Merck’s Life Science business sector has secured a contract award worth €121m from the US Department of Defense (DoD) to construct a lateral flow membrane production facility at the company’s site in Sheboygan, Wisconsin. The new facility will produce the company’s Hi-Flow Plus lateral flow membrane, which is used in rapid diagnostic test kit manufacturing, including Covid-19. The contract awarded on behalf of the US Department of Health and Human Services, will help ensure secure supply and production capacity locally for critical products to prepare for the pandemic.
